Antigen of hybrid M protein and carrier for group A streptococcal vaccine
US7074416B2 · kind B2 · utility
5Cited by
16References
30Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 7, 2002 |
| Grant date | Jul 11, 2006 |
| Priority date | — |
| Expiry date | May 7, 2022 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant hybrid streptococcal M protein antigens are provided which elicit protective antibodies against Group A streptococci and prevent rheumatic fever. Recombinant hybrid genes which encode the antigen are provided. Vaccine compositions and methods of administering the compositions are provided to elicit immunity against Group A streptococci.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.